KCM
TIL icon

Kalehua Capital Management’s Instil Bio TIL Stock Holding History

Kalehua Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$766K Sell
99,600
-83,430
-46% -$673K 0.44% 25
2026
Q1 		$1.51M Buy
+183,030
New +$1.48M 1.07% 20

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Kalehua Capital Management's TIL Position: Q2 2026 in Review

Kalehua Capital Management reduced its Instil Bio (TIL) stake by 46% in Q2 2026, selling an estimated $673K and leaving 99,600 shares worth $766K. The position accounts for 0.44% of the portfolio, ranked #25.

Kalehua Capital Management first reported a position in TIL in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.51M in Q1 2026. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Kalehua Capital Management held 99,600 shares of Instil Bio worth $766K as of Q2 2026.
  • Kalehua Capital Management sold 83,430 Instil Bio shares in Q2 2026, an estimated $673K.
  • Instil Bio made up 0.44% of Kalehua Capital Management's portfolio in Q2 2026, its #25 holding.
  • Kalehua Capital Management first reported a position in Instil Bio in Q1 2026 and has held it in 2 quarters since.
  • Kalehua Capital Management's Instil Bio position peaked at $1.51M in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Kalehua Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.